HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Aziz, H. S. Articles by Khan, M. A. Search for Related Content PubMed PubMed Citation Articles by Aziz, H. S. Articles by Khan, M. A.

Serum Magnesium Levels and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective Study

Address correspondence to M. Anees Khan, M.D., Division of Pulmonary Diseases, St. Joseph’s Regional Medical Center, 703 Main St., Paterson, NJ 07503, USA tel 973 754 2450; fax 973 754 2469; e-mail khana{at}sjhmc.org.

A decrease in serum Mg⁺² is associated with airway hyper-reactivity and impaired pulmonary function. The purpose of this study was to determine if decreased serum Mg⁺² levels in patients with chronic obstructive pulmonary disease (COPD) are associated with acute exacerbations. In a retrospective study, the charted serum Mg⁺² levels in 100 COPD patients were examined. These included 50 patients who presented with an acute exacerbation of COPD and 50 stable patients. Chart review was sequential within both groups. Serum Mg²⁺ levels in the stable COPD patients averaged 0.91 ± 0.10 mmol/L (mean ± SD) with a 95% CI of 0.88 – 0.94 mmol/L. Patients undergoing an exacerbation had significantly lower serum Mg⁺² levels (0.77 ± 0.10 mmol/L; CI, 0.74 – 0.79; p <0.0001). Logistic regression of the dichotomous outcomes as a function of serum Mg⁺² concentration demonstrated a highly significant association (² = 41.26; p <10^–5). These data were subjected to receiver-operator characteristic (ROC) analysis for decision levels (DL) and the area under the ROC curve was determined to be 0.85 ± 0.04 (CI, 0.78 – 0.93). The optimum DL was determined to lie between 0.80 mmol/L (OR = 14.33; sensitivity 70%; specificity 86%) and 0.84 mmol/L (OR = 11.16; sensitivity 84%; specificity 68%). These data suggest that at the lower range of the reference interval, serum Mg⁺² levels are associated with an increased risk of exacerbation of symptoms in COPD patients. Furthermore, they suggest a DL that is useful for predicting clinical outcomes in these patients and serving as a target value for therapy.

Keywords: serum Mg⁺², magnesium, chronic obstructive pulmonary disease

This article has been cited by other articles:

				V. A. DeBari Computation of decision levels from differentiated logistic regression probability curves. Ann. Clin. Lab. Sci., March 1, 2006; 36(2): 194 - 200. [Abstract] [Full Text] [PDF]